Skip to main content
. Author manuscript; available in PMC: 2009 Jan 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2008 Jan;14(Supplement 1):6–11. doi: 10.1016/j.bbmt.2007.10.026

Figure 2.

Figure 2

Predicting outcome post autologous peripheral blood stem cell transplant based on cardiac biomarker staging system.

Stage 1, both below biomarkers below cut-off; Stage 2, one of the two biomarkers below cut-off; and Stage 3, both biomarkers above cut-offs. Cut-offs troponin T < 0.035 mcg/L and NT-proBNP < 332 ng/L (39 pmol/L). Results updated from original publication published in Blood. 2004;104:1881-1887. Median follow-up of surviving patients is 35.5 months.